Tienilic Acid: Pharmacokinetics, Salicylate Interaction and Creatinine Secretion Studies
Overview
Affiliations
Tienilic acid is a diuretic-uricosuric compound whose natriuretic site of action is in the cortical diluting segment of the distal nephron. Oral doses of 250 mg given to normal human volunteers provided peak blood levels of 10--11 micrograms/ml at 3--4 hours after administration. Approximately 40% of the dose was recovered in 24 hours, 30% as the parent compound and 10% as the alcohol and diacid metabolites. A 650 mg dose of acetylsalicylic acid significantly decreased the uricosuric effect of tienilic acid by inhibiting uric acid secretion. Urine pH fell significantly with tienilic acid administration. Tienilic acid inhibited salicylate excretion by either competition for tubular secretion or by increasing passive, pH dependent reabsorption. In normal subjects given a creatinine load, tienilic acid did not inhibit creatinine secretion.
Risk assessment of mechanism-based inactivation in drug-drug interactions.
Fujioka Y, Kunze K, Isoherranen N Drug Metab Dispos. 2012; 40(9):1653-7.
PMID: 22685217 PMC: 3422541. DOI: 10.1124/dmd.112.046649.
Pharmacokinetic and pharmacodynamic studies of tienilic acid in healthy volunteers.
Kerremans A, Gribnau F, Tan Y, van Ginneken C Eur J Clin Pharmacol. 1982; 22(6):515-21.
PMID: 7128663 DOI: 10.1007/BF00609624.
Diuretics. Clinical pharmacology and therapeutic use (Part II).
Lant A Drugs. 1985; 29(2):162-88.
PMID: 3884320 DOI: 10.2165/00003495-198529020-00003.
Immune mechanisms in tienilic acid associated hepatotoxicity.
Neuberger J, Williams R Gut. 1989; 30(4):515-9.
PMID: 2714684 PMC: 1434040. DOI: 10.1136/gut.30.4.515.